Petmed Express, Inc. (PETS) Company Profile & Statistics

Petmed Express, Inc.
PETS
(Nasdaq - US)
Open
6.83
-0.41 (-5.66%)
in:usd•As of: Nov 30, 2023 12:52 UTC -5
Open
7.12
High
7.12
Low
6.82

About Petmed Express, Inc.

CEO

Mathew N. Hulett

Headquarters

420 south congress avenue

delray beach, fl 33445, united states

Auditor

RSM US LLP

Employees

302

Share Holders

134

Website

www.1800petmeds.com

Industry

specialty stores

Sector

retail trade

Company Overview

PetMed Express, Inc. and subsidiaries, d/b/a 1-800-PetMeds (the `Company`), is a leading nationwide pet pharmacy. The Company markets prescription and non-prescription pet medications, health products, and supplies for dogs and cats, direct to the consumer. The Company offers consumers an attractive alternative for obtaining pet medications in terms of convenience, price, and speed of delivery. The Company markets its products through national advertising campaigns, which aim to increase the recognition of the `1-800-PetMeds` brand name, and `PetMeds` family of trademarks, increase traffic on its website at www.1800petmeds.com, acquire new customers, and maximize repeat purchases. The majority of the Company's sales are to residents in the United States. The Company's corporate headquarters and distribution facility are located in Delray Beach, Florida.

Petmed Express, Inc. Statistics

Valuation Measures

Market Capitalization ²	144.45M
Enterprise Value	90.98M
Enterprise Value/EBITDA (ttm)	-17.76
Price to Earnings Ratio (ttm)	121.83
Price to Book (mrq)	1.36
Price to Sales (ttm)	0.57
Price to Cash (ytd)	13.88

Profitability

Gross Margin (ttm)	27.70%
Operating Margin (ttm)	0.42%
Profit Margin (ttm)	-2.36%
Return on Equity (ttm)	0.93%
Return on Invested Capital (ttm)	-4.95%
Return on Assets (ttm)	0.68%

Income Statement

Revenue (ttm)	270.52M
Revenue Per Share (ttm)	12.79
Gross Profit (ttm)	75.21M
EBITDA (ttm)³	-5.12M
Net Income Avi to Common (ttm)	-6.08M
Diluted EPS (ttm)	-0.29

Share Statistics

Beta (5Y Monthly)	0.70
52-Week Change	-63.46%
S&P500 52-Week Change	11.34%
S&P500 Member	No
Stock Optionable	Yes
Total Shares Outstanding ¹	21.15M
Dividend Yield	16.42%
Float ⁴	20.39M
% Held by Insiders	3.60%
% Held by Institutions	74.99%

Balance Sheet

Total Cash (mrq)	53.47M
Total Cash Per Share (mrq)	2.53
Total Debt (mrq)	0.00
Total Debt/Equity (mrq)	0.00%
Current Ratio (mrq)	2.10%
Quick Ratio (mrq)	1.64%
Book Value Per Share (mrq)	5.38

Cash Flow

Operating Cash Flow Per Share (ytd)	-0.01
Free Cash Flow (ytd)	-2.35M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. Stock price provided by Xignite. All numbers are rounded to the closest decimal.

¹ Total Shares outstanding is taken from the most recently filed quarterly or annual report.

² Market Cap is calculated using total shares outstanding and the most recent share price.

³ EBITDA is calculated using methodology that may differ from that used by a company in its reporting.

⁴ The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

Petmed Express, Inc.

Trade With A Regulated Broker